Our overall results led to the conclusion that early DC at 6 months after RAI therapy with rhTSH represents the most balanced solution considering possible additional information provided by DC after withdrawal of thyroid hormone weighed against symptoms of hypothyroidism. This evidence concerns the gene TG and hypothyroidism.